These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

86 related articles for article (PubMed ID: 17560878)

  • 1. The editor's roundtable: high-density lipoprotein cholesterol.
    Friedewald VE; Brewer HB; Grundy SM; Rader DJ; Roberts WC
    Am J Cardiol; 2007 Jun; 99(12):1698-705. PubMed ID: 17560878
    [No Abstract]   [Full Text] [Related]  

  • 2. The importance of recognizing and treating low levels of high-density lipoprotein cholesterol: a new era in atherosclerosis management.
    Cardenas GA; Lavie CJ; Cardenas V; Milani RV; McCullough PA
    Rev Cardiovasc Med; 2008; 9(4):239-58. PubMed ID: 19122582
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effects of increasing high-density lipoprotein cholesterol and decreasing low-density lipoprotein cholesterol on the incidence of first acute coronary events (from the Air Force/Texas Coronary Atherosclerosis Prevention Study).
    Cui Y; Watson DJ; Girman CJ; Shapiro DR; Gotto AM; Hiserote P; Clearfield MB
    Am J Cardiol; 2009 Sep; 104(6):829-34. PubMed ID: 19733719
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The editor's roundtable: the JUPITER trial--initial results and clinical implications.
    Ridker PM; Friedewald VE; Davidson MH; Willerson JT; Roberts WC
    Am J Cardiol; 2009 May; 103(10):1417-25. PubMed ID: 19427439
    [No Abstract]   [Full Text] [Related]  

  • 5. Targeting residual cardiovascular risk: raising high-density lipoprotein cholesterol levels.
    Hausenloy DJ; Yellon DM
    Heart; 2008 Jun; 94(6):706-14. PubMed ID: 18480348
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The significance of plasma high density lipoprotein cholesterol (hdlc).
    Gupta S; Rajagopal G
    Nepal Med Coll J; 2007 Sep; 9(3):212-4. PubMed ID: 18092443
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Shedding light on high-density lipoprotein cholesterol: the post-ILLUMINATE era.
    Lavie CJ; Milani RV
    J Am Coll Cardiol; 2008 Jan; 51(1):56-8. PubMed ID: 18174037
    [No Abstract]   [Full Text] [Related]  

  • 8. Dose-dependent effect of rosuvastatin treatment on HDL-subfraction phenotype in patients with primary hyperlipidemia.
    Kostapanos MS; Milionis HJ; Filippatos TD; Christogiannis LG; Bairaktari ET; Tselepis AD; Elisaf MS
    J Cardiovasc Pharmacol Ther; 2009 Mar; 14(1):5-13. PubMed ID: 19246334
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prevalence of low high-density lipoprotein cholesterol in patients with documented coronary heart disease or risk equivalent and controlled low-density lipoprotein cholesterol.
    Alsheikh-Ali AA; Lin JL; Abourjaily P; Ahearn D; Kuvin JT; Karas RH
    Am J Cardiol; 2007 Nov; 100(10):1499-501. PubMed ID: 17996508
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Beyond LDL cholesterol: the role of elevated triglycerides and low HDL cholesterol in residual CVD risk remaining after statin therapy.
    Alagona P
    Am J Manag Care; 2009 Mar; 15(3 Suppl):S65-73. PubMed ID: 19355805
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prevention and treatment of atherosclerosis: a practitioner's guide for 2008.
    Lewis SJ
    Am J Med; 2009 Jan; 122(1 Suppl):S38-50. PubMed ID: 19110087
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Regression of atherosclerosis demands low LDL targets and raised HDL levels.
    Cardiovasc J Afr; 2008; 19(4):221. PubMed ID: 18776971
    [No Abstract]   [Full Text] [Related]  

  • 13. Clinical significance of high-density lipoprotein cholesterol in patients with low low-density lipoprotein cholesterol.
    deGoma EM; Leeper NJ; Heidenreich PA
    J Am Coll Cardiol; 2008 Jan; 51(1):49-55. PubMed ID: 18174036
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The editor's roundtable: lipid management beyond statins-reducing residual cardiovascular risk.
    Friedewald VE; Ballantyne CM; Davidson MH; Guyton JR; Roberts WC
    Am J Cardiol; 2008 Sep; 102(5):559-67. PubMed ID: 18721512
    [No Abstract]   [Full Text] [Related]  

  • 15. [Intervention study for elevating high density lipoprotein cholesterol level].
    Kodama S; Sone H
    Nihon Rinsho; 2007 Jul; 65 Suppl 7():264-9. PubMed ID: 17824044
    [No Abstract]   [Full Text] [Related]  

  • 16. Evidence to support aggressive management of high-density lipoprotein cholesterol: implications of recent imaging trials.
    Taylor AJ
    Am J Cardiol; 2008 Apr; 101(8A):36B-43B. PubMed ID: 18375240
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Achieving cholesterol goals. Current and future drug therapies.
    Jones PH
    Postgrad Med; 2003 Aug; 114(2 Suppl):14-21. PubMed ID: 19667635
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Is there evidence-based hypolipidemic treatment with clinical benefit beyond statins?
    Goumas GS
    Angiology; 2009; 60(1):93-8. PubMed ID: 19019838
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The editor's roundtable: Acute decompensated heart failure.
    Friedewald VE; Gheorghiade M; Yancy CW; Young JB; Roberts WC
    Am J Cardiol; 2007 Jun; 99(11):1560-7. PubMed ID: 17531581
    [No Abstract]   [Full Text] [Related]  

  • 20. High-density lipoprotein metabolism: potential therapeutic targets.
    Davidson MH; Toth PP
    Am J Cardiol; 2007 Dec; 100(11 A):n32-40. PubMed ID: 18047851
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.